T1	Participants 86 106	diffuse lung disease
T2	Participants 223 261	evaluation of diffuse lung infiltrates
T3	Participants 579 618	diffuse parenchymal lung disease (DPLD)
T4	Participants 668 740	95 patients who underwent fluoroscopy guided TBLB over a two year period
T5	Participants 742 821	Patients with a lung mass or solitary lung nodule undergoing TBLB were excluded
T6	Participants 2080 2113	diffuse infiltrative lung disease
